GSK pays Rs 6,400 crore to increase stake in GSK Pharma to 75%: Report

10 Mar 2014 Evaluate

GlaxoSmithKline (GSK) has reportedly paid Rs 6,400 crore to raise its stake in its Indian pharmaceuticals unit -- GlaxoSmithKline Pharmaceuticals (GSK Pharma) -- to 75%, as it banks on rising demand for medicines in emerging markets.

The Britain’s biggest drug-maker first announced plans to lift the holding in GSK Pharma from 50.7% in December 2013. It held an open offer to buy the extra shares at Rs 3,100 each from February 18 to March 5. Moreover, final payment for shares tendered and accepted will be completed by March 20.

As on December 2013, the promoters holding in the company stood at 50.67%, while institutions and non-institutions held 33.97% and 15.36% stake in the company, respectively.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxosmithkline Phar Share Price

2380.90 3.25 (0.14%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×